Core Nursing Explanation
Key Concept Analysis: This question assesses the nurse's understanding of
perioperative glycemic management for a patient with diabetes mellitus (DM). The core principle is maintaining blood glucose within a target range (typically
140-180 mg/dL) to prevent both hyperglycemia-related complications (infection, poor wound healing, hyperosmolar state) and intraoperative hypoglycemia. Major surgery induces a significant stress response, releasing counter-regulatory hormones (cortisol, epinephrine, glucagon) that cause insulin resistance and hyperglycemia. Therefore, a passive approach (holding medications) is dangerous, and a fixed-dose strategy (full or half dose) is inadequate for the dynamic metabolic changes of surgery.
Answer Rationale:
Key Point! The most appropriate intervention is
Initiate continuous glucose monitoring and prepare for intraoperative insulin protocol. This represents the current evidence-based standard of care.
210 mg/dL is elevated and requires active management. A continuous insulin infusion (IV insulin drip) allows for precise, titratable control in response to frequent blood glucose checks, which is far safer and more effective than subcutaneous insulin in the unstable perioperative period. Preparing for this protocol is the nurse's critical preoperative responsibility.
Distractor Analysis:
Watch out for confusion!
①
Administer the client's usual morning insulin dose: This is incorrect and dangerous. The patient will be NPO (Nothing by mouth) for surgery, increasing the risk of severe hypoglycemia from long-acting or intermediate-acting insulin. Usual home regimens are typically held or modified.
②
Hold all diabetes medications until after surgery: This is incorrect. With a blood glucose of
210 mg/dL, doing nothing will lead to worsening hyperglycemia, increasing the risk of dehydration, ketoacidosis (in type 1 DM), and surgical complications.
③
Give only half the usual insulin dose: This is an unsafe guess. While dose adjustment may be part of a specific protocol, arbitrarily giving half a dose without a dynamic management plan does not address the need for continuous monitoring and titration. It still carries a risk of hypoglycemia or inadequate control.
Related Concepts: Perioperative management focuses on minimizing metabolic stress. For type 1 diabetics, preventing
Diabetic ketoacidosis (DKA) is critical, as they are insulin-dependent. For type 2 diabetics, preventing
Hyperosmolar hyperglycemic state (HHS) is a concern. The goal is to use
IV insulin infusion for its short half-life and easy titration, transitioning back to subcutaneous insulin only when the patient is stable and eating postoperatively.
Concept Summary
| Concept | Key Takeaway |
|---|
| Perioperative Hyperglycemia Risk | Surgical stress causes insulin resistance and hyperglycemia, increasing infection and mortality risk. |
| Target Blood Glucose | Aim for 140-180 mg/dL during the perioperative period for most patients. |
| Management Strategy | Dynamic management with frequent monitoring (every 1-2 hours) and IV insulin infusion is the gold standard for major surgery. |
| Hypoglycemia Prevention | The greatest fear during NPO status and anesthesia. IV insulin allows immediate cessation if glucose drops. |
Side-by-Side Comparison!
| Management Approach | Rationale & Use Case | Risk |
|---|
| IV Insulin Infusion Protocol (Correct Answer) | For major surgery, unstable patients, or poor pre-op control. Allows minute-to-minute titration. | Requires frequent monitoring; risk of hypoglycemia if not managed carefully. |
| Hold All Oral Agents/Insulin (Distractor) | Rarely appropriate. May be considered for minor procedures in well-controlled type 2 DM on short-acting agents only. | High risk of severe hyperglycemia and its complications. |
| Reduced Subcutaneous Dose (Distractor) | Sometimes used for minor procedures or as part of a specific, written protocol. | Unpredictable absorption; cannot be quickly reversed; poor control for major stress. |
Anatomy, Physiology & Pharmacology Points
- Physiology: Surgical stress activates the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system, increasing cortisol and catecholamines. These hormones promote gluconeogenesis and glycogenolysis (raising blood sugar) while causing insulin resistance.
- Pharmacology: IV regular insulin has a very short half-life (~5-10 minutes). This makes it ideal for infusion, as its effects can be stopped almost immediately if hypoglycemia occurs. In contrast, subcutaneous insulin (especially long-acting) has a prolonged duration of action that cannot be reversed.
Memory Tips
- Acronym: S.T.R.E.S.S. = Surgical Time Requires Expert Sugar Surveillance.
- Rule of Thumb: "Major surgery, major stress, needs major control" → Think IV insulin drip.
- Number to Remember: Keep glucose < 180. If it's over 180 pre-op, active management (like a drip) is needed.
High-Frequency NCLEX Topics
This is a
Core priority and safety topic. The NCLEX loves to test the nurse's role in
preventing complications. You must know that holding all meds or giving a fixed dose is wrong, and that active, monitored management (like an insulin drip) is correct for unstable or surgical patients. Expect questions on signs of hypo/hyperglycemia and which action to take first.
Watch Out for Question Variations!
- Shift in Priority: The question could ask for the first action. The first action is often to notify the surgeon/anesthesiologist of the elevated glucose, as they need to order the insulin protocol.
- Postoperative Focus: "A post-op diabetic patient has a blood glucose of 60 mg/dL. What is the priority?" Answer: Administer fast-acting carbohydrate (e.g., juice) or IV dextrose per protocol, as hypoglycemia is an immediate threat.
- Medication Specific: They may ask which specific preoperative medication to hold (e.g., Metformin is often held 24-48 hours prior to surgery to reduce risk of lactic acidosis from contrast dye or hypoperfusion).